FEBS Letters · 2005 · 204 citations · 21 references
MedicineCell BiologyOncologyChemotherapyMetastasisMolecular OncologyBreast Cancer OncologyCancer Cell SignalingCancer ProgressionMetastatic Breast CancerMetastatic Signaling PathwaysSphingolipid MetabolismBreast Cancer ChemotherapyBreast Cancer ProgressionBreast Cancer Resistance MechanismsMetastatic Breast Cancer BiologySensitivitySphingolipid SignalingSphingosine 1-Phosphate SignalingSphingosine-1-phosphate Signaling
Sphingosine-1-phosphate (S1P) is a potent lysolipid involved in a variety of biological responses important for cancer progression. Therefore, we investigated the role of sphingosine kinase type 1 (SphK1), the enzyme that makes S1P, in the motility, growth, and chemoresistance of MCF-7 breast cancer cells. Epidermal growth factor (EGF), an important growth factor for breast cancer progression, activated and translocated SphK1 to plasma membrane. SphK1 was required for EGF-directed motility. Downregulation of SphK1 in MCF-7 cells reduced EGF- and serum-stimulated growth and enhanced sensitivity to doxorubicin, a potent chemotherapeutic agent. These results suggest that SphK1 may be critical for growth, metastasis and chemoresistance of human breast cancers.
21
Role of the Sphingosine-1-Phosphate Receptor EDG-1 in PDGF-Induced Cell Motility
John P. Hobson, Hans Rosenfeldt, Larry S. Barak et al. · Science · 2001 · 427 citations